Archimedes Tech SPAC Partners II Co. - Ordinary Shares (ATII)

On our desk, we are closely tracking ATII's trading band around $10.65 as it approaches the Forge Nano merger vote. The valuation reference point of $1.2 billion gives us a baseline, but the $135 million H1 2026 loss reported in the 10-Q—heavily impacted by the $100 million PIPE expense—demands careful scrutiny of their post-merger burn rate and cash runway.

From a risk management standpoint, the capital structure heading into the business combination looks tight. While there is $244.2 million left in the Trust Account for redemptions, the working capital deficit stands at $138.0 million alongside a meager $414,970 in cash outside the trust. We are hedging our exposure until redemption figures clear up.

As a quant analyst looking at the order book and volume metrics (averaging around low thousands daily with a $314M+ market cap), liquidity remains constrained. The warrants included in the $100M PIPE subscription (15,000,000 warrants attached to 10,000,000 Pubco shares) introduce potential future dilution dynamics that options desks must price into the post-merger surface.

When analyzing Forge Nano's fundamental backing for the interview process or pitch books, emphasize their proprietary Atomic Layer Deposition (ALD) platform. Their portfolio of 200+ patents, $2B+ pipeline, and $84M in binding off-take agreements for AI-era chips and defense batteries provide the core secular narrative supporting the $359 billion addressable market target.

Retail sentiment tracked via platforms like Rallies and Sirius Investors shows mild bullish engagement, with ATII up 2.50% year-to-date. However, message volume suggests participants are primarily waiting for the SEC to declare the Form S-4 registration statement effective following the July filing amendments.

Our hedge fund's macro committee notes that special purpose acquisition vehicles in the shell companies sector require strict milestone verification. The recent filing of the Form S-4 amendment on July 24, 2026, moves the timeline forward, but investors must weigh the hefty derivative liability increases against the long-term industrial potential of Forge Nano.